GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 209 filers reported holding GENMAB A/S in Q1 2023. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $495,590 | -14.6% | 15,565 | -5.4% | 0.11% | -20.9% |
| Q3 2023 | $580,227 | -10.3% | 16,451 | -3.3% | 0.13% | -6.9% |
| Q2 2023 | $646,702 | -11.4% | 17,014 | -1.2% | 0.14% | -18.2% |
| Q4 2022 | $729,741 | -99.9% | 17,219 | -0.3% | 0.18% | +21.4% |
| Q3 2022 | $554,821,000 | -3.5% | 17,268 | +0.4% | 0.14% | +2.1% |
| Q2 2022 | $574,829,000 | -7.9% | 17,195 | -0.4% | 0.14% | -2.1% |
| Q1 2022 | $624,358,000 | -9.4% | 17,257 | -0.9% | 0.14% | -7.1% |
| Q4 2021 | $688,937,000 | -7.6% | 17,415 | +2.1% | 0.16% | -13.3% |
| Q3 2021 | $745,347,000 | +3.9% | 17,056 | -1.2% | 0.18% | +4.7% |
| Q2 2021 | $717,319,000 | +42.0% | 17,264 | +12.5% | 0.17% | +33.3% |
| Q1 2021 | $505,300,000 | – | 15,340 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |